|
1
|
Boellaard R, Delgado-Bolton R, Oyen WJG,
Giammarile F, Tatsch K, Eschner W, Verzijlbergen FJ, Barrington SF,
Pike LC, Weber WA; European Association of Nuclear Medicine (EANM);
et al: FDG PET/CT: EANM procedure guidelines for tumour imaging:
version 2.0. Eur J Nucl Med Mol Imaging. 42:328–354. 2015.
View Article : Google Scholar :
|
|
2
|
Pfannenberg AC, Aschoff P, Brechtel K,
Müller M, Klein M, Bares R, Claussen CD and Eschmann SM: Value of
contrast-enhanced multiphase CT in combined PET/CT protocols for
oncological imaging. Br J Radiol. 80:437–445. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Bashir U, Mallia A, Stirling J, Joemon J,
MacKewn J, Charles-Edwards G, Goh V and Cook GJ: PET/MRI in
Oncological Imaging: State of the Art. Diagnostics (Basel).
5:333–357. 2015. View Article : Google Scholar
|
|
4
|
Broski SM, Goenka AH, Kemp BJ and Johnson
GB: Clinical PET/MRI: 2018 Update. AJR Am J Roentgenol.
211:295–313. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Papadakis GZ, Manikis GC, Hannah-Shmouni
F, O’Brien KJ, Gahl WA and Estrada-Veras JI: Higher metabolic
activity seen on 18F-FDG PET/CT, in the adrenal glands
of patients with Erdheim-Chester Disease harboring the BRAF V600E
mutation. Pediatr Blood Cancer. 64(Suppl): S29. 2017.
|
|
6
|
Papadakis GZ, Patronas NJ, Chen CC, Carney
JA and Stratakis CA: Combined PET/CT by 18F-FDOPA,
18F-FDA, 18F-FDG, and MRI correlation on a
patient with Carney triad. Clin Nucl Med. 40:70–72. 2015.
View Article : Google Scholar
|
|
7
|
Diker-Cohen T, Abraham SB, Rauschecker M,
Papadakis GZ, Munir KM, Brown E, Lyssikatos C, Belyavskaya E,
Merino M and Stratakis CA: Reninoma presenting in pregnancy. J Clin
Endocrinol Metab. 99:2625–2626. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
Karageorgiadis AS, Papadakis GZ, Biro J,
Keil MF, Lyssikatos C, Quezado MM, Merino M, Schrump DS, Kebebew E,
Patronas NJ, et al: Ectopic adrenocorticotropic hormone and
corticotropin-releasing hormone co-secreting tumors in children and
adolescents causing cushing syndrome: A diagnostic dilemma and how
to solve it. J Clin Endocrinol Metab. 100:141–148. 2015. View Article : Google Scholar :
|
|
9
|
Hammoud DA, Boulougoura A, Papadakis GZ,
Wang J, Dodd LE, Rupert A, Higgins J, Roby G, Metzger D, Laidlaw E,
et al: Increased metabolic activity on
18F-Fluorodeoxyglucose positron emission
tomography-computed tomography in human immunodeficiency
virus-associated immune reconstitution inflammatory syndrome. Clin
Infect Dis. 68:229–238. 2019. View Article : Google Scholar
|
|
10
|
Hannah-Shmouni F, Papadakis GZ, Stratakis
CA and Blau J: Enlarging hypermetabolic nodule: Benign
non-functional adrenocortical adenoma. BMJ Case Rep.
2017:bcr20172208202017. View Article : Google Scholar
|
|
11
|
Papadakis GZ, Millo C and Stratakis CA:
Benign hormone-secreting adenoma within a larger adrenocortical
mass showing intensely increased activity on 18F-FDG
PET/CT. Endocrine. 54:269–270. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Papadakis GZ, Holland SM, Quezado M and
Patronas NJ: Adrenal cryptococcosis in an immunosuppressed patient
showing intensely increased metabolic activity on
18F-FDG PET/CT. Endocrine. 54:834–836. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Papadakis GZ, Millo C, Bagci U, Patronas
NJ and Stratakis CA: Talc pleurodesis with intense
18F-FDG activity but no 68Ga-DOTA-TATE
activity on PET/CT. Clin Nucl Med. 40:819–820. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Bastawrous S, Bhargava P, Behnia F, Djang
DS and Haseley DR: Newer PET application with an old tracer: Role
of 18F-NaF skeletal PET/CT in oncologic practice.
Radiographics. 34:1295–1316. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Papadakis GZ, Jha S, Bhattacharyya T,
Millo C, Tu TW, Bagci U, Marias K, Karantanas AH and Patronas NJ:
18F-NaF PET/CT in extensive melorheostosis of the axial
and appendicular Skeleton With Soft-Tissue Involvement. Clin Nucl
Med. 42:537–539. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Papadakis GZ, Jha S, Karantanas AH, Marias
K, Bagci U and Bhattacharyya T: Prospective evaluation of the
application of 18F-NaF PET/CT imaging in melorheostosis.
Eur J Nucl Med Mol Imaging. 45(Suppl 1): S231–S232. 2018.
|
|
17
|
Papadakis GZ, Millo C, Bagci U, Blau J and
Collins MT: 18F-NaF and 18F-FDG PET/CT in
Gorham-Stout Disease. Clin Nucl Med. 41:884–885. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Papadakis GZ, Millo C, Bagci U, Patronas
NJ and Collins MT: Value of 18F-NaF PET/CT imaging in
the assessment of Gorham-Stout disease activity. Eur J Nucl Med Mol
Imaging. 43(Suppl 1): S597. 2016. View Article : Google Scholar
|
|
19
|
Hofman MS, Lau WF and Hicks RJ:
Somatostatin receptor imaging with 68Ga DOTATATE PET/CT:
Clinical utility, normal patterns, pearls, and pitfalls in
interpretation. Radiographics. 35:500–516. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Tirosh A, Papadakis GZ, Millo C, Hammoud
D, Sadowski SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P,
et al: Prognostic utility of total 68Ga-DOTATATE-avid
tumor volume in patients with neuroendocrine tumors.
Gastroenterology. 154:998–1008.e1. 2018. View Article : Google Scholar
|
|
21
|
Tirosh A, Papadakis GZ, Millo C, Sadowski
SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, et
al: Association between neuroendocrine tumors biomarkers and
primary tumor site and disease type based on total
68Ga-DOTATATE-Avid tumor volume measurements. Eur J
Endocrinol. 176:575–582. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Papadakis GZ, Millo C, Sadowski SM,
Karantanas AH, Bagci U and Patronas NJ: Fibrous Dysplasia Mimicking
Malignancy on 68Ga-DOTATATE PET/CT. Clin Nucl Med.
42:209–210. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Papadakis GZ, Sadowski SM, Bagci U and
Millo C: Application of 68Ga-DOTA-TATE PET/CT in
metastatic neuroendocrine tumor of gastrointestinal origin. Ann
Gastroenterol. 30:1302017.
|
|
24
|
Papadakis GZ, Millo C, Jassel IS, Bagci U,
Sadowski SM, Karantanas AH and Patronas NJ: 18F-FDG and
68Ga-DOTATATE PET/CT in von Hippel-Lindau
disease-associated retinal heman-gioblastoma. Clin Nucl Med.
42:189–190. 2017. View Article : Google Scholar
|
|
25
|
Papadakis GZ, Millo C, Karantanas AH,
Bagci U and Patronas NJ: Avascular necrosis of the hips with
increased activity on 68Ga-DOTATATE PET/CT. Clin Nucl
Med. 42:214–215. 2017. View Article : Google Scholar :
|
|
26
|
Papadakis GZ, Millo C, Sadowski SM,
Karantanas AH, Bagci U and Patronas NJ: Breast fibroadenoma with
increased activity on 68Ga DOTATATE PET/CT. Clin Nucl
Med. 42:145–146. 2017. View Article : Google Scholar :
|
|
27
|
Papadakis GZ, Millo C, Sadowski SM, Bagci
U and Patronas NJ: Kidney Tumor in a von Hippel-Lindau (VHL)
patient with intensely increased activity on
68Ga-DOTA-TATE PET/CT. Clin Nucl Med. 41:970–971. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
28
|
El-Maouche D, Sadowski SM, Papadakis GZ,
Guthrie L, Cottle-Delisle C, Merkel R, Millo C, Chen CC, Kebebew E
and Collins MT: 68Ga-DOTATATE for tumor localization in
tumor-induced osteomalacia. J Clin Endocrinol Metab. 101:3575–3581.
2016. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Papadakis GZ, Millo C, Sadowski SM, Bagci
U and Patronas NJ: Epididymal cystadenomas in von Hippel-Lindau
disease showing increased activity on 68Ga DOTATATE
PET/CT. Clin Nucl Med. 41:781–782. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Papadakis GZ, Millo C, Sadowski SM, Bagci
U and Patronas NJ: Endolymphatic sac tumor showing increased
activity on 68Ga-DOTATATE PET/CT. Clin Nucl Med.
41:783–784. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Papadakis GZ, Millo C, Bagci U, Sadowski
SM and Stratakis CA: Schmorl nodes can cause increased
68Ga-DOTATATE activity on PET/CT, mimicking metastasis
in patients with neuroendocrine malignancy. Clin Nucl Med.
41:249–250. 2016. View Article : Google Scholar :
|
|
32
|
Papadakis GZ, Bagci U, Sadowski SM,
Patronas NJ and Stratakis CA: Ectopic ACTH and CRH co-secreting
tumor localized by 68Ga-DOTA-TATE PET/CT. Clin Nucl Med.
40:576–578. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Tirosh A, Papadakis GZ, Millo C, Sadowski
SM, Herscovitch P, Pacak K, Marx SJ, Yang L, Nockel P, Shell J, et
al: High total 68Ga-DOTATATE-Avid Tumor Volume (TV) is
associated with low progression-free survival and high
disease-specific mortality rate in patients with neuroendocrine
tumors. Endocrine Abstracts. 49:OC7.32017.
|
|
34
|
Honavar SG and Manjandavida FP: Recent
Advances in Orbital Tumors - A Review of Publications from
2014-2016. Asia Pac J Ophthalmol (Phila). 6:153–158. 2017.
|
|
35
|
Hui KH, Pfeiffer ML and Esmaeli B: Value
of positron emission tomography/computed tomography in diagnosis
and staging of primary ocular and orbital tumors. Saudi J
Ophthalmol. 26:365–371. 2012. View Article : Google Scholar
|
|
36
|
Purohit BS, Vargas MI, Ailianou A, Merlini
L, Poletti PA, Platon A, Delattre BM, Rager O, Burkhardt K and
Becker M: Orbital tumours and tumour-like lesions: Exploring the
arma-mentarium of multiparametric imaging. Insights Imaging.
7:43–68. 2016. View Article : Google Scholar
|
|
37
|
English JF and Sullivan TJ: The Role of
FDG-PET in the diagnosis and staging of ocular adnexal
lymphoproliferative disease. Orbit. 34:284–291. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
38
|
Valenzuela AA, Allen C, Grimes D, Wong D
and Sullivan TJ: Positron emission tomography in the detection and
staging of ocular adnexal lymphoproliferative disease.
Ophthalmology. 113:2331–2337. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
39
|
Roe RH, Finger PT, Kurli M, Tena LB and
Iacob CE: Whole-body positron emission tomography/computed
tomography imaging and staging of orbital lymphoma. Ophthalmology.
113:1854–1858. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
40
|
Suga K, Yasuhiko K, Hiyama A, Takeda K and
Matsunaga N: 18F-FDG PET/CT findings in a patient with
bilateral orbital and gastric mucosa-associated lymphoid tissue
lymphomas. Clin Nucl Med. 34:589–593. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
41
|
Gayed I, Eskandari MF, McLaughlin P, Pro
B, Diba R and Esmaeli B: Value of positron emission tomography in
staging ocular adnexal lymphomas and evaluating their response to
therapy. Ophthalmic Surg Lasers Imaging. 38:319–325. 2007.
View Article : Google Scholar : PubMed/NCBI
|
|
42
|
Sallak A, Besson FL, Pomoni A, Christinat
A, Adler M, Aegerter JP, Nguyen C, de Leval L, Frossard V and Prior
JO: Conjunctival MALT lymphoma: Utility of FDG PET/CT for
diagnosis, staging, and evaluation of treatment response. Clin Nucl
Med. 39:295–297. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
43
|
Yildirim-Poyraz N, Ozdemir E, Basturk A,
Kilicarslan A and Turkolmez S: PET/CT findings in a case with
FDG-avid disseminated lacrimal gland MALToma with sequential
development of large B-cell lymphoma and gastric MALToma. Clin Nucl
Med. 40:141–145. 2015. View Article : Google Scholar
|
|
44
|
Fujii H, Tanaka H, Nomoto Y, Harata N,
Oota S, Isogai J and Yoshida K: Usefulness of 18F-FDG
PET/CT for evaluating response of ocular adnexal lymphoma to
treatment. Medicine (Baltimore). 97:e05432018. View Article : Google Scholar
|
|
45
|
Hu DN, Yu GP, McCormick SA, Schneider S
and Finger PT: Population-based incidence of uveal melanoma in
various races and ethnic groups. Am J Ophthalmol. 140:612–617.
2005. View Article : Google Scholar : PubMed/NCBI
|
|
46
|
Singh AD, Turell ME and Topham AK: Uveal
melanoma: Trends in incidence, treatment, and survival.
Ophthalmology. 118:1881–1885. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
47
|
Finger PT, Kurli M, Wesley P, Tena L, Kerr
KR and Pavlick A: Whole body PET/CT imaging for detection of
metastatic choroidal melanoma. Br J Ophthalmol. 88:1095–1097. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
48
|
Reddy S, Kurli M, Tena LB and Finger PT:
PET/CT imaging: Detection of choroidal melanoma. Br J Ophthalmol.
89:1265–1269. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
49
|
Finger PT, Chin K and Iacob CE:
18-Fluorine-labelled 2 - deoxy-2 -fluoro - D – glucose positron
emission tomography/computed tomography standardised uptake values:
A non-invasive biomarker for the risk of metastasis from choroidal
melanoma. Br J Ophthalmol. 90:1263–1266. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
50
|
Matsuo T, Ogino Y, Ichimura K, Tanaka T
and Kaji M: Clinicopathological correlation for the role of
fluorodeoxy-glucose positron emission tomography computed
tomography in detection of choroidal malignant melanoma. Int J Clin
Oncol. 19:230–239. 2014. View Article : Google Scholar
|
|
51
|
McCannel TA, Reddy S, Burgess BL and
Auerbach M: Association of positive dual-modality positron emission
tomography/computed tomography imaging of primary choroidal
melanoma with chromosome 3 loss and tumor size. Retina. 30:146–151.
2010. View Article : Google Scholar
|
|
52
|
Papastefanou VP, Islam S, Szyszko T,
Grantham M, Sagoo MS and Cohen VML: Metabolic activity of primary
uveal melanoma on PET/CT scan and its relationship with monosomy 3
and other prognostic factors. Br J Ophthalmol. 98:1659–1665. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
53
|
Kurli M, Reddy S, Tena LB, Pavlick AC and
Finger PT: Whole body positron emission tomography/computed
tomography staging of metastatic choroidal melanoma. Am J
Ophthalmol. 140:193–199. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
54
|
Freton A, Chin KJ, Raut R, Tena LB, Kivelä
T and Finger PT: Initial PET/CT staging for choroidal melanoma:
AJCC correlation and second nonocular primaries in 333 patients.
Eur J Ophthalmol. 22:236–243. 2012. View Article : Google Scholar
|
|
55
|
Strobel K, Bode B, Dummer R, Veit-Haibach
P, Fischer DR, Imhof L, Goldinger S, Steinert HC and von Schulthess
GK: Limited value of 18F-FDG PET/CT and S-100B tumour
marker in the detection of liver metastases from uveal melanoma
compared to liver metastases from cutaneous melanoma. Eur J Nucl
Med Mol Imaging. 36:1774–1782. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
56
|
Orcurto V, Denys A, Voelter V,
Schalenbourg A, Schnyder P, Zografos L, Leyvraz S, Delaloye AB and
Prior JO: (18) F-fluorodeoxyglucose positron emission
tomography/computed tomography and magnetic resonance imaging in
patients with liver metastases from uveal melanoma: Results from a
pilot study. Melanoma Res. 22:63–69. 2012. View Article : Google Scholar
|
|
57
|
Ries LAG, Smith MA, Gurney JG, Linet M,
Tamra T, Young JL and Bunin GR: Cancer incidence and survival among
children and adolescents: United States SEER program 1975-1995.
(NIH Pub No 99-4649). National Cancer Institute; Bethesda, MD:
1999
|
|
58
|
Jakobiec FA, Tso MO, Zimmerman LE and
Danis P: Retinoblastoma and intracranial malignancy. Cancer.
39:2048–2058. 1977. View Article : Google Scholar : PubMed/NCBI
|
|
59
|
de Jong MC, Kors WA, de Graaf P,
Castelijns JA, Kivelä T and Moll AC: Trilateral retinoblastoma: A
systematic review and meta-analysis. Lancet Oncol. 15:1157–1167.
2014. View Article : Google Scholar : PubMed/NCBI
|
|
60
|
Kamihara J, Bourdeaut F, Foulkes WD,
Molenaar JJ, Mossé YP, Nakagawara A, Parareda A, Scollon SR,
Schneider KW, Skalet AH, et al: Retinoblastoma and Neuroblastoma
Predisposition and Surveillance. Clin Cancer Res. 23:e98-e1062017.
View Article : Google Scholar : PubMed/NCBI
|
|
61
|
Yamanaka R, Hayano A and Takashima Y:
Trilateral retinoblastoma: A systematic review of 211 cases.
Neurosurg Rev. 42:39–48. 2019. View Article : Google Scholar
|
|
62
|
Honavar SG, Manjandavida FP and Reddy VAP:
Orbital retinoblastoma: An update. Indian J Ophthalmol. 65:435–442.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
63
|
Radhakrishnan V, Kumar R, Malhotra A and
Bakhshi S: Role of PET/CT in staging and evaluation of treatment
response after 3 cycles of chemotherapy in locally advanced
retinoblastoma: A prospective study. J Nucl Med. 53:191–198. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
64
|
Yu GP, Hu DN, McCormick S and Finger PT:
Conjunctival melanoma: Is it increasing in the United States? Am J
Ophthalmol. 135:800–806. 2003. View Article : Google Scholar : PubMed/NCBI
|
|
65
|
Folberg R, McLean IW and Zimmerman LE:
Malignant melanoma of the conjunctiva. Hum Pathol. 16:136–143.
1985. View Article : Google Scholar : PubMed/NCBI
|
|
66
|
Damian A, Gaudiano J, Engler H and Alonso
O: (18)F-FDG PET-CT for Staging of Conjunctival Melanoma. World J
Nucl Med. 12:45–47. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
67
|
Tuomaala S and Kivelä T: Metastatic
pattern and survival in disseminated conjunctival melanoma:
Implications for sentinel lymph node biopsy. Ophthalmology.
111:816–821. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
68
|
Kurli M, Chin K and Finger PT: Whole-body
18 FDG PET/CT imaging for lymph node and metastatic staging of
conjunctival melanoma. Br J Ophthalmol. 92:479–482. 2008.
View Article : Google Scholar : PubMed/NCBI
|
|
69
|
Tsai SY, Shiau YC, Wang SY and Wu YW:
Conjunctival Melanoma on 18F-FDG PET/CT as a Second
Primary Cancer. Clin Nucl Med. 41:237–238. 2016. View Article : Google Scholar
|
|
70
|
Muqit MM, Foot B, Walters SJ, Mudhar HS,
Roberts F and Rennie IG: Observational prospective cohort study of
patients with newly-diagnosed ocular sebaceous carcinoma. Br J
Ophthalmol. 97:47–51. 2013. View Article : Google Scholar
|
|
71
|
Yin VT, Merritt HA, Sniegowski M and
Esmaeli B: Eyelid and ocular surface carcinoma: Diagnosis and
management. Clin Dermatol. 33:159–169. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
72
|
Shields JA, Demirci H, Marr BP, Eagle RC
Jr and Shields CL: Sebaceous carcinoma of the eyelids: Personal
experience with 60 cases. Ophthalmology. 111:2151–2157. 2004.
View Article : Google Scholar : PubMed/NCBI
|
|
73
|
Baek CH, Chung MK, Jeong HS, Son YI, Choi
J, Kim YD, Choi JY, Kim HJ and Ko YH: The clinical usefulness of
(18) F-FDG PET/CT for the evaluation of lymph node metastasis in
periorbital malignancies. Korean J Radiol. 10:1–7. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
74
|
Krishna SM, Finger PT, Chin K and Lacob
CE: 18-FDG PET/CT staging of ocular sebaceous cell carcinoma.
Graefes Arch Clin Exp Ophthalmol. 245:759–760. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
75
|
Ishiguro Y, Homma S, Yoshida T, Ohno Y,
Ichikawa N, Kawamura H, Hata H, Kase S, Ishida S, Okada-Kanno H, et
al: Usefulness of PET/CT for early detection of internal
malignancies in patients with Muir-Torre syndrome: Report of two
cases. Surg Case Rep. 3:712017. View Article : Google Scholar : PubMed/NCBI
|
|
76
|
Faustina M, Diba R, Ahmadi MA and Esmaeli
B: Patterns of regional and distant metastasis in patients with
eyelid and peri-ocular squamous cell carcinoma. Ophthalmology.
111:1930–1932. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
77
|
Donaldson MJ, Sullivan TJ, Whitehead KJ
and Williamson RM: Squamous cell carcinoma of the eyelids. Br J
Ophthalmol. 86:1161–1165. 2002. View Article : Google Scholar : PubMed/NCBI
|
|
78
|
Soysal HG and Markoç F: Invasive squamous
cell carcinoma of the eyelids and periorbital region. Br J
Ophthalmol. 91:325–329. 2007. View Article : Google Scholar
|
|
79
|
Reifler DM and Hornblass A: Squamous cell
carcinoma of the eyelid. Surv Ophthalmol. 30:349–365. 1986.
View Article : Google Scholar : PubMed/NCBI
|
|
80
|
Yi JS, Kim JS, Lee JH, Choi SH, Nam SY,
Kim SY and Roh JL: 18F-FDG PET/CT for detecting distant
metastases in patients with recurrent head and neck squamous cell
carcinoma. J Surg Oncol. 106:708–712. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
81
|
Lin LF, Chang CY and Cherng SC: Advanced
squamous cell carcinoma of the bulbar conjunctiva seen on PET/CT.
Clin Nucl Med. 33:929–930. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
82
|
Abdelmalik AG, Fajnwaks P, Osman MM and
Nguyen NC: Squamous cell carcinoma of the bulbar conjunctiva seen
on F-18 FDG PET/CT. Clin Nucl Med. 35:962–964. 2010. View Article : Google Scholar
|
|
83
|
Jurdy L, Merks JHM, Pieters BR, Mourits
MP, Kloos RJ, Strackee SD and Saeed P: Orbital rhabdomyosarcomas: A
review. Saudi J Ophthalmol. 27:167–175. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
84
|
Norman G, Fayter D, Lewis-Light K,
Chisholm J, McHugh K, Levine D, Jenney M, Mandeville H, Gatz S and
Phillips B: An emerging evidence base for PET-CT in the management
of childhood rhabdomyosarcoma: Systematic review. BMJ Open.
5:e0060302015. View Article : Google Scholar : PubMed/NCBI
|
|
85
|
Harrison DJ, Parisi MT and Shulkin BL: The
Role of 18F-FDG-PET/CT in Pediatric Sarcoma. Semin Nucl
Med. 47:229–241. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
86
|
Teixeira SR, Martinez-Rios C, Hu L and
Bangert BA: Clinical applications of pediatric positron emission
tomography-magnetic resonance imaging. Semin Roentgenol.
49:353–366. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
87
|
Nair AG, Pathak RS, Iyer VR and Gandhi RA:
Optic nerve glioma: An update. Int Ophthalmol. 34:999–1005. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
88
|
Becker M, Masterson K, Delavelle J,
Viallon M, Vargas MI and Becker CD: Imaging of the optic nerve. Eur
J Radiol. 74:299–313. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
89
|
Campen CJ and Gutmann DH: Optic Pathway
Gliomas in Neurofibromatosis Type 1. J Child Neurol. 33:73–81.
2018. View Article : Google Scholar
|
|
90
|
Miyamoto J, Sasajima H, Owada K and
Mineura K: Surgical decision for adult optic glioma based on
[18F]fluorodeoxy-glucose positron emission tomography study. Neurol
Med Chir (Tokyo). 46:500–503. 2006. View Article : Google Scholar
|
|
91
|
Peng F, Juhasz C, Bhambhani K, Wu D,
Chugani DC and Chugani HT: Assessment of progression and treatment
response of optic pathway glioma with positron emission tomography
using alpha-[(11)C]methyl-L-tryptophan. Mol Imaging Biol.
9:106–109. 2007. View Article : Google Scholar : PubMed/NCBI
|
|
92
|
Moharir M, London K, Howman-Giles R and
North K: Utility of positron emission tomography for tumour
surveillance in children with neurofibromatosis type 1. Eur J Nucl
Med Mol Imaging. 37:1309–1317. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
93
|
Roselli F, Pisciotta NM, Aniello MS,
Niccoli-Asabella A, Defazio G, Livrea P and Rubini G: Brain F-18
Fluorocholine PET/CT for the assessment of optic pathway glioma in
neurofi-bromatosis-1. Clin Nucl Med. 35:838–839. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
94
|
Rizzo V, Mattoli MV, Trevisi G, Coli A,
Calcagni ML and Montano N: Optic nerve glioblastoma detected by
11C-Methionine brain PET/CT. Rev Esp Med Nucl Imagen
Mol. 37:259–260. 2018.
|
|
95
|
Nakajima R, Kimura K, Abe K and Sakai S:
11C-methionine PET/CT findings in benign brain disease.
Jpn J Radiol. 35:279–288. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
96
|
Konstantinidis L and Damato B: Intraocular
Metastases - A Review. Asia Pac J Ophthalmol (Phila). 6:208–214.
2017.
|
|
97
|
Konstantinidis L, Rospond-Kubiak I,
Zeolite I, Heimann H, Groenewald C, Coupland SE and Damato B:
Management of patients with uveal metastases at the Liverpool
Ocular Oncology Centre. Br J Ophthalmol. 98:92–98. 2014. View Article : Google Scholar
|
|
98
|
Donaldson MJ, Pulido JS, Mullan BP,
Inwards DJ, Cantrill H, Johnson MR and Han MK: Combined positron
emission tomography/computed tomography for evaluation of presumed
choroidal metastases. Clin Exp Ophthalmol. 34:846–851. 2006.
View Article : Google Scholar : PubMed/NCBI
|
|
99
|
Shields JA, Shields CL and Scartozzi R:
Survey of 1264 patients with orbital tumors and simulating lesions:
The 2002 Montgomery Lecture, part 1. Ophthalmology. 111:997–1008.
2004. View Article : Google Scholar : PubMed/NCBI
|
|
100
|
Valenzuela AA, Archibald CW, Fleming B,
Ong L, O’Donnell B, Crompton JJ, Selva D, McNab AA and Sullivan TJ:
Orbital metastasis: Clinical features, management and outcome.
Orbit. 28:153–159. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
101
|
Das S, Pineda G, Goff L, Sobel R, Berlin J
and Fisher G: The eye of the beholder: Orbital metastases from
midgut neuroendocrine tumors, a two institution experience. Cancer
Imaging. 18:472018. View Article : Google Scholar : PubMed/NCBI
|
|
102
|
Ding ZX, Lip G and Chong V: Idiopathic
orbital pseudotumour. Clin Radiol. 66:886–892. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
103
|
Weber AL, Romo LV and Sabates NR:
Pseudotumor of the orbit. Clinical, pathologic, and radiologic
evaluation. Radiol Clin North Am. 37:151–168. xi1999. View Article : Google Scholar : PubMed/NCBI
|
|
104
|
Pakdaman MN, Sepahdari AR and Elkhamary
SM: Orbital inflammatory disease: Pictorial review and differential
diagnosis. World J Radiol. 6:106–115. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
105
|
Patnana M, Sevrukov AB, Elsayes KM,
Viswanathan C, Lubner M and Menias CO: Inflammatory pseudotumor:
The great mimicker. AJR Am J Roentgenol. 198:W217–27. 2012.
View Article : Google Scholar : PubMed/NCBI
|
|
106
|
Alongi F, Bolognesi A, Samanes Gajate AM,
Motta M, Landoni C, Berardi G, Alongi P, Gianolli L and Di Muzio N:
Inflammatory pseudotumor of mediastinum treated with tomotherapy
and monitored with FDG-PET/CT: Case report and literature review.
Tumori. 96:322–326. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
107
|
Boyce AM, Florenzano P, de Castro LF,
Collins MT, Adam MP, Ardinger HH, Pagon RA, Wallace SE, Bean LJH,
Stephens K and Amemiya A: Fibrous Dysplasia/McCune-Albright
Syndrome In: GeneReviews® [Internet]. University of
Washington; Seattle, WA: 1993-2019
|
|
108
|
Collins MT, Kushner H, Reynolds JC, Chebli
C, Kelly MH, Gupta A, Brillante B, Leet AI, Riminucci M, Robey PG,
et al: An instrument to measure skeletal burden and predict
functional outcome in fibrous dysplasia of bone. J Bone Miner Res.
20:219–226. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
109
|
Toba M, Hayashida K, Imakita S, Fukuchi K,
Kume N, Shimotsu Y, Cho I, Ishida Y, Takamiya M and Kumita S:
Increased bone mineral turnover without increased glucose
utilization in sclerotic and hyperplastic change in fibrous
dysplasia. Ann Nucl Med. 12:153–155. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
110
|
Shigesawa T, Sugawara Y, Shinohara I,
Fujii T, Mochizuki T and Morishige I: Bone metastasis detected by
FDG PET in a patient with breast cancer and fibrous dysplasia. Clin
Nucl Med. 30:571–573. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
111
|
Stegger L, Juergens KU, Kliesch S,
Wormanns D and Weckesser M: Unexpected finding of elevated glucose
uptake in fibrous dysplasia mimicking malignancy: Contradicting
metabolism and morphology in combined PET/CT. Eur Radiol.
17:1784–1786. 2007. View Article : Google Scholar
|
|
112
|
Su MG, Tian R, Fan QP, Tian Y, Li FL, Li
L, Kuang AR and Miller JH: Recognition of fibrous dysplasia of bone
mimicking skeletal metastasis on 18F-FDG PET/CT imaging.
Skeletal Radiol. 40:295–302. 2011. View Article : Google Scholar
|
|
113
|
D’Souza MM, Jaimini A, Khurana A, Tripathi
M, Sharma R, Mondal A and Srivastava M: Polyostotic fibrous
dysplasia on F-18 FDG PET/CT imaging. Clin Nucl Med. 34:359–361.
2009. View Article : Google Scholar
|
|
114
|
Kim M, Kim HS, Kim JH, Jang JH, Chung KJ,
Shin MK, Hwang HS, Kim BC and Jung SY: F-18 FDG PET-positive
fibrous dysplasia in a patient with intestinal non-Hodgkin’s
lymphoma. Cancer Res Treat. 41:171–174. 2009. View Article : Google Scholar : PubMed/NCBI
|
|
115
|
Choi YY, Kim JY and Yang SO: PET/CT in
benign and malignant musculoskeletal tumors and tumor-like
conditions. Semin Musculoskelet Radiol. 18:133–148. 2014.
View Article : Google Scholar : PubMed/NCBI
|
|
116
|
Kamaleshwaran KK, Joseph J, Kalarikal R
and Shinto AS: Image Findings of Polyostotic Fibrous Dysplasia
Mimicking Metastasis in F-18 FDG Positron Emission
Tomography/Computed Tomography. Indian J Nucl Med. 32:137–139.
2017. View Article : Google Scholar : PubMed/NCBI
|
|
117
|
Ruggieri P, Sim FH, Bond JR and Unni KK:
Malignancies in fibrous dysplasia. Cancer. 73:1411–1424. 1994.
View Article : Google Scholar : PubMed/NCBI
|
|
118
|
Wei WJ, Sun ZK, Shen CT, Zhang XY, Tang J,
Song HJ, Qiu ZL and Luo QY: Value of 99mTc-MDP SPECT/CT
and 18F-FDG PET/CT scanning in the evaluation of
malignantly transformed fibrous dysplasia. Am J Nucl Med Mol
Imaging. 7:92–104. 2017.
|
|
119
|
Chen CC, Czerwiec FS and Feuillan PP:
Visualization of fibrous dysplasia during somatostatin receptor
scintigraphy. J Nucl Med. 39:238–240. 1998.PubMed/NCBI
|
|
120
|
Papadakis GZ, Manikis GC, Karantanas AH,
Florenzano P, Bagci U, Marias K, Collins MT and Boyce AM:
18F-NaF PET/CT imaging in fibrous dysplasia of bone. J
Bone Miner Res. 34:1619–1631. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
121
|
Papadakis G, Manikis G, Karantanas A,
Marias K, Bagci U, Florenzano P, Collins M and Boyce A: Fibrous
dysplasia related 18F-NaF activity in the spine is
significantly higher in patients with scoliosis, compared to
patients without spinal deformity. J Nucl Med. 60(Suppl 1): 1298S.
2019.
|
|
122
|
Papadakis G, Manikis G, Karantanas A,
Marias K, Bagci U, Florenzano P, Collins M and Boyce A: Positive
Association between Fibrous Dysplasia (FD) related
18F-NaF activity and Bone Turnover Markers (BTMs). J
Nucl Med. 60(Suppl 1): 90S. 2019.
|
|
123
|
Papadakis G, Manikis G, Karantanas A,
Marias K, Collins M and Boyce A: Application of 18F-NaF
PET/CT imaging in prognosis of fractures and treatment planning in
patients with fibrous dysplasia. J Nucl Med. 58(Suppl 1): 308S.
2017.
|
|
124
|
Papadakis GZ, Manikis GC, Karantanas AH,
Marias K, Collins MT and Boyce AM: Application of
18F-NaF PET/CT imaging in fibrous dysplasia. Horm Res
Paediatr. 88(Suppl 1): 20. 2017.
|
|
125
|
Delso G, Fürst S, Jakoby B, Ladebeck R,
Ganter C, Nekolla SG, Schwaiger M and Ziegler SI: Performance
measurements of the Siemens mMR integrated whole-body PET/MR
scanner. J Nucl Med. 52:1914–1922. 2011. View Article : Google Scholar : PubMed/NCBI
|
|
126
|
Levin CS, Maramraju SH, Khalighi MM,
Deller TW, Delso G and Jansen F: Design features and mu-tual
compatibility studies of the time-of-flight PET capable GE SIGNA
PET/MR system. IEEE Trans Med Imaging. 35:1907–1914. 2016.
View Article : Google Scholar : PubMed/NCBI
|
|
127
|
Partovi S, Kohan A, Rubbert C,
Vercher-Conejero JL, Gaeta C, Yuh R, Zipp L, Herrmann KA, Robbin
MR, Lee Z, et al: Clinical oncologic applications of PET/MRI: A new
horizon. Am J Nucl Med Mol Imaging. 4:202–212. 2014.PubMed/NCBI
|
|
128
|
Varoquaux A, Rager O, Poncet A, Delattre
BM, Ratib O, Becker CD, Dulguerov P, Dulguerov N, Zaidi H and
Becker M: Detection and quantification of focal uptake in head and
neck tumours: (18)F-FDG PET/MR versus PET/CT. Eur J Nucl Med Mol
Imaging. 41:462–475. 2014. View Article : Google Scholar
|
|
129
|
Platzek I, Beuthien-Baumann B, Langner J,
Popp M, Schramm G, Ordemann R, Laniado M, Kotzerke J and van den
Hoff J: PET/MR for therapy response evaluation in malignant
lymphoma: Initial experience. MAGMA. 26:49–55. 2013. View Article : Google Scholar :
|
|
130
|
Papadakis GZ, Karantanas AH, Tsiknakis M,
Tsatsakis A, Spandidos DA and Marias K: Deep learning opens new
horizons in personalized medicine. Biomed Rep. 10:215–217.
2019.PubMed/NCBI
|
